Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.
about
Implication of snoRNA U50 in human breast cancerChemo-resistant protein expression pattern of glioblastoma cells (A172) to perillyl alcohol.Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line.Integrative genome comparison of primary and metastatic melanomas.MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancerCDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signalingClinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: coordinate involvement of the regions including BCR and ABL.FKBPL: a marker of good prognosis in breast cancer.Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy.Challenges in identifying candidate amplification targets in human cancers: chromosome 8q21 as a case study.The role of S6K1 in ER-positive breast cancer.High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancerIdentification of Copy Number Aberrations in Breast Cancer Subtypes Using Persistence Topology.Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array.Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer.Molecular markers of breast axillary lymph node metastasis.The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL.A review of the biological and clinical characteristics of luminal-like oestrogen receptor-positive breast cancer.Hide and seek: tell-tale signs of breast cancer lurking in the blood.Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach.Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy.Genomic signatures of breast cancer metastasis.Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer.Identification of polymorphisms in cancer patients that differentially affect survival with age.
P2860
Q24594639-6B3B3B69-366D-4EDC-9339-AB3E5330DEA6Q30497846-5CBDC7E3-4C55-413F-9D5D-41ECA1892156Q33443512-8D843774-223B-42C4-9D60-E87351B869F2Q33592837-2EF70C71-8362-4AD5-AEF1-8909011E7F4CQ33694015-F2C633A3-3F00-47DD-912B-16A31199BA83Q34049223-9EB9EC36-213B-47AF-BFAA-85CB39284A46Q34067578-1708D323-921F-42F0-85F5-F098BD774D77Q34464472-37DF51A5-E9A6-456F-A05E-FAA400E30E69Q35785776-10717392-342F-410D-8857-99ED3B3675E3Q35828542-CE36861A-CBB5-4A8A-AE87-E5B27A6CDFF4Q35928654-959CA54A-EE16-447E-A6E9-29BEE9987866Q36230602-26A01C3B-3A36-4243-8462-E7DBD6B9E4DBQ36296457-C6AE7908-A18A-4948-8746-5139CAB9F335Q36304094-40E86F50-5E76-4105-A409-B094BC24EB4BQ36465618-A86FA5A8-420D-46AD-B85E-3B0E4005A569Q37200784-1AADB5BC-D053-4B5B-8DBD-5A77C0C54702Q37290013-F5DF8365-6FB4-4574-BB15-8C4211F0B8F2Q37380558-5AF2DA8E-FE6F-481A-B51B-CD1A965A2800Q37472659-7A072E8D-7348-458E-A1E6-224A53CE676EQ37542255-F04FC055-78A9-4247-BF10-0E585B58C81FQ37856424-ABAD16FE-08BD-424C-A9B1-9146706B946FQ37929842-DA8CE3D1-EF7D-4D43-A146-9768DE5289D0Q38056383-4D49D856-9DA6-472E-B3D1-30DBD147C4AFQ39672356-0D34C840-3CE6-4906-972C-2878A14B685EQ41896118-C25BEC96-4DAE-4E9E-8294-BDB4153B48BEQ42259243-418E97B0-6506-4690-ACE8-979C0BDBEEB0Q44638273-70DEB512-4313-4331-872B-8F27425C2427Q46158806-7A0B4054-C5D0-4C56-8541-C5CEDF0FE89CQ47114556-5EC82736-A8AD-4916-8E89-967FB3CDC02F
P2860
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Genomic alterations identified ...... ceptor-positive breast cancer.
@ast
Genomic alterations identified ...... ceptor-positive breast cancer.
@en
type
label
Genomic alterations identified ...... ceptor-positive breast cancer.
@ast
Genomic alterations identified ...... ceptor-positive breast cancer.
@en
prefLabel
Genomic alterations identified ...... ceptor-positive breast cancer.
@ast
Genomic alterations identified ...... ceptor-positive breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Genomic alterations identified ...... ceptor-positive breast cancer.
@en
P2093
Hyuk-Jae Shin
Jason Jongho Kang
Ji Hyun Lee
Ji-Yeon Bae
Ki-Tae Hwang
Mi-Ryung Han
Sung-Eun Hwang
Sung-Won Kim
Wonshik Han
Young Ju Bae
P2860
P2888
P356
10.1186/1471-2407-6-92
P407
P577
2006-04-12T00:00:00Z
P5875
P6179
1044916600